Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The global heart failure drugs market is generic in nature; as many generic drug manufacturers and pharmaceutical giants are providing drugs for a disease. However; the arrival of innovative drugs such as EOM, is expected to change the market dynamics. AstraZeneca and Novartis hold the major share of the global heart failure drugs market with their drugs Toprol-XL and wog, respectively. The companies also hold a strong pipeline and are expected to remain the market leaders during the forecast period. Based on the drug class the market can be segmented into Beta blockers, ARBs, and ACE inhibitors. Angiotensin II receptor blockers (ARB) are a group of pharmaceuticals that modify the renin-angiotensin system. The heart disease drugs market is experiencing growth in the ARBs segment because it reduces the risk of death caused by heart failure and minimizes the chance of hospitalization of people with heart failure.
The latest trend gaining momentum in the market is investment inclination toward developing countries. Countries such as India, China, and Brazil are turning out to be some of the most attractive countries for pharmaceutical companies across the globe. Many factors such as huge share of global population and rising geriatric population are leading to the high growth of healthcare sector in the developing countries. In addition, the rising cases of lifestyle disorders such as obesity and diabetes also contribute to higher heart failure cases in the region.One of the major drivers for this market is rising geriatric population. A large number of health problems are associated with the rising age, and CVDs are major among them. As a person gets older, the blood vessels become less flexible, thus making it difficult for the blood to flow through them. Rising age accompanied by other factors such as lifestyle-oriented diseases and smoking increases the risk of CVDs, especially heart failure. Heart failure in the geriatric population will continue to be a rising health burden globally, as this population represents the majority of the heart failure patients. Hence, rising geriatric population drives the demand for heart failure drugs during the forecast period.
This report elaborates on the current development of the Heart Failure Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Pfizer
Gilead
AstraZeneca
Amgen
Bayer
GlaxoSmithKline
Novartis
By Type:
ARBs
Beta Blockers
ACE Inhibitors
By Application:
Pharmacy
Others
Hospital
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Heart Failure Drugs Market Overview 2018-2029
-
1.1 China Heart Failure Drugs Industry Development Overview
-
1.2 China Heart Failure Drugs Industry Development History
-
1.3 China Heart Failure Drugs Industry Market Size (2018-2029)
-
1.4 China Heart Failure Drugs Market Analysis by Type from Production Side
-
1.4.1 China Heart Failure Drugs Production Volume, Production Value and Growth Rate of ARBs (2018-2029)
-
1.4.2 China Heart Failure Drugs Production Volume, Production Value and Growth Rate of Beta Blockers (2018-2029)
-
1.4.3 China Heart Failure Drugs Production Volume, Production Value and Growth Rate of ACE Inhibitors (2018-2029)
-
1.5 China Heart Failure Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Heart Failure Drugs Sales Volume, Sales Value and Growth Rate of Pharmacy (2018-2029)
-
1.5.2 China Heart Failure Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.3 China Heart Failure Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.6 China Heart Failure Drugs Market Analysis by Region
-
1.6.1 North China Heart Failure Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Heart Failure Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Heart Failure Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Heart Failure Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Heart Failure Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Heart Failure Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Heart Failure Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Heart Failure Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Heart Failure Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Heart Failure Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Heart Failure Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Heart Failure Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Heart Failure Drugs Industry Development
Chapter 3 Heart Failure DrugsIndustry Chain Analysis
-
3.1 Heart Failure Drugs Industry Chain
-
3.2 Heart Failure Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Heart Failure Drugs Market
-
3.3 Heart Failure Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Heart Failure Drugs Market
Chapter 4 China Heart Failure Drugs Market, by Type
-
4.1 China Heart Failure Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Heart Failure Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Heart Failure Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Heart Failure Drugs Production Volume and Growth Rate of ARBs
-
4.5.2 China Heart Failure Drugs Production Volume and Growth Rate of Beta Blockers
-
4.5.3 China Heart Failure Drugs Production Volume and Growth Rate of ACE Inhibitors
Chapter 5 China Heart Failure Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Heart Failure Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Heart Failure Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Heart Failure Drugs Market Size and Growth Rate of Pharmacy
-
5.5.2 China Heart Failure Drugs Market Size and Growth Rate of Others
-
5.5.3 China Heart Failure Drugs Market Size and Growth Rate of Hospital
Chapter 6 China Heart Failure Drugs Market, by Region
-
6.1 China Heart Failure Drugs Production Volume and Production Value, by Region
-
6.2 China Heart Failure Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Heart Failure Drugs Market Analysis
-
7.1 North China Heart Failure Drugs Market, by Type
-
7.2 North China Heart Failure Drugs Market, by Application
Chapter 8 Central China Heart Failure Drugs Market Analysis
-
8.1 Central China Heart Failure Drugs Market, by Type
-
8.2 Central China Heart Failure Drugs Market, by Application
Chapter 9 South China Heart Failure Drugs Market Analysis
-
9.1 South China Heart Failure Drugs Market, by Type
-
9.2 South China Heart Failure Drugs Market, by Application
Chapter 10 East China Heart Failure Drugs Market Analysis
-
10.1 East China Heart Failure Drugs Market, by Type
-
10.2 East China Heart Failure Drugs Market, by Application
Chapter 11 Northeast China Heart Failure Drugs Market Analysis
-
11.1 Northeast China Heart Failure Drugs Market, by Type
-
11.2 Northeast China Heart Failure Drugs Market, by Application
Chapter 12 Southwest China Heart Failure Drugs Market Analysis
-
12.1 Southwest China Heart Failure Drugs Market, by Type
-
12.2 Southwest China Heart Failure Drugs Market, by Application
Chapter 13 Northwest China Heart Failure Drugs Market Analysis
-
13.1 Northwest China Heart Failure Drugs Market, by Type
-
13.2 Northwest China Heart Failure Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Pfizer
-
14.1.1 Pfizer Company Profile
-
14.1.2 Pfizer Heart Failure Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Gilead
-
14.2.1 Gilead Company Profile
-
14.2.2 Gilead Heart Failure Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Profile
-
14.3.2 AstraZeneca Heart Failure Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Amgen
-
14.4.1 Amgen Company Profile
-
14.4.2 Amgen Heart Failure Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Bayer
-
14.5.1 Bayer Company Profile
-
14.5.2 Bayer Heart Failure Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 GlaxoSmithKline
-
14.6.1 GlaxoSmithKline Company Profile
-
14.6.2 GlaxoSmithKline Heart Failure Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Novartis
-
14.7.1 Novartis Company Profile
-
14.7.2 Novartis Heart Failure Drugs Market Performance
-
14.7.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Heart Failure Drugs Industry Research Conclusions
-
15.2 Heart Failure Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Heart Failure Drugs Industry Market Size (2018-2029)
-
Figure China Heart Failure Drugs Production Volume, Production Value and Growth Rate of ARBs (2018-2029)
-
Figure China Heart Failure Drugs Production Volume, Production Value and Growth Rate of Beta Blockers (2018-2029)
-
Figure China Heart Failure Drugs Production Volume, Production Value and Growth Rate of ACE Inhibitors (2018-2029)
-
Figure China Heart Failure Drugs Sales Volume, Sales Value and Growth Rate of Pharmacy (2018-2029)
-
Figure China Heart Failure Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Heart Failure Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure North China Heart Failure Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Heart Failure Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Heart Failure Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Heart Failure Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Heart Failure Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Heart Failure Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Heart Failure Drugs Market Size and Growth Rate from 2018-2029
-
Figure Heart Failure Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Heart Failure Drugs Market Share by Type in 2018
-
Figure China Heart Failure Drugs Market Share by Type in 2023
-
Figure China Heart Failure Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Heart Failure Drugs Production Volume and Growth Rate of ARBs (2018-2023)
-
Figure China Heart Failure Drugs Production Volume and Growth Rate of Beta Blockers (2018-2023)
-
Figure China Heart Failure Drugs Production Volume and Growth Rate of ACE Inhibitors (2018-2023)
-
Figure China Heart Failure Drugs Market Share by Application in 2018
-
Figure China Heart Failure Drugs Market Share by Application in 2023
-
Figure China Heart Failure Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Heart Failure Drugs Market Size and Growth Rate of Pharmacy (2018-2023)
-
Figure China Heart Failure Drugs Market Size and Growth Rate of Others (2018-2023)
-
Figure China Heart Failure Drugs Market Size and Growth Rate of Hospital (2018-2023)
-
Table China Heart Failure Drugs Production Volume by Region (2018-2023)
-
Table China Heart Failure Drugs Production Volume Share by Region (2018-2023)
-
Figure China Heart Failure Drugs Production Volume Share by Region (2018-2023)
-
Table China Heart Failure Drugs Production Value by Region (2018-2023)
-
Table China Heart Failure Drugs Production Value Share by Region (2018-2023)
-
Figure China Heart Failure Drugs Production Value Share by Region (2018-2023)
-
Table China Heart Failure Drugs Sales Volume by Region (2018-2023)
-
Table China Heart Failure Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Heart Failure Drugs Sales Volume Share by Region (2018-2023)
-
Table China Heart Failure Drugs Sales Value by Region (2018-2023)
-
Table China Heart Failure Drugs Sales Value Share by Region (2018-2023)
-
Figure China Heart Failure Drugs Sales Value Share by Region (2018-2023)
-
Table North China Heart Failure Drugs Production Volume by Type (2018-2023)
-
Table North China Heart Failure Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Heart Failure Drugs Production Volume Share by Type (2018-2023)
-
Table North China Heart Failure Drugs Sales Volume by Application (2018-2023)
-
Table North China Heart Failure Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Heart Failure Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Heart Failure Drugs Production Volume by Type (2018-2023)
-
Table Central China Heart Failure Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Heart Failure Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Heart Failure Drugs Sales Volume by Application (2018-2023)
-
Table Central China Heart Failure Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Heart Failure Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Heart Failure Drugs Production Volume by Type (2018-2023)
-
Table South China Heart Failure Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Heart Failure Drugs Production Volume Share by Type (2018-2023)
-
Table South China Heart Failure Drugs Sales Volume by Application (2018-2023)
-
Table South China Heart Failure Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Heart Failure Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Heart Failure Drugs Production Volume by Type (2018-2023)
-
Table East China Heart Failure Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Heart Failure Drugs Production Volume Share by Type (2018-2023)
-
Table East China Heart Failure Drugs Sales Volume by Application (2018-2023)
-
Table East China Heart Failure Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Heart Failure Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Heart Failure Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Heart Failure Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Heart Failure Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Heart Failure Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Heart Failure Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Heart Failure Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Heart Failure Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Heart Failure Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Heart Failure Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Heart Failure Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Heart Failure Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Heart Failure Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Heart Failure Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Heart Failure Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Heart Failure Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Heart Failure Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Heart Failure Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Heart Failure Drugs Sales Volume Share by Application (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Heart Failure Drugs Revenue, Price and Gross (2018-2023)
-
Table Gilead Company Profile
-
Table Gilead Heart Failure Drugs Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Heart Failure Drugs Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Heart Failure Drugs Revenue, Price and Gross (2018-2023)
-
Table Bayer Company Profile
-
Table Bayer Heart Failure Drugs Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Heart Failure Drugs Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Heart Failure Drugs Revenue, Price and Gross (2018-2023)
-
